• Users Online: 114
  • Print this page
  • Email this page

    Article Cited by others

BRIEF REPORT

Macrolides and COVID-19: An optimum premise

Al-Kuraishy Hayder M, Al-Naimi Marwa S, Lungnier Claire M, Al-Gareeb Ali I

Year : 2020| Volume: 4| Issue : 3 | Page no: 189-192

   This article has been cited by
 
1 The potential role of neopterin in Covid-19: a new perspective
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Khalid J. Alzahrani,Natália Cruz-Martins,Gaber El-Saber Batiha
Molecular and Cellular Biochemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Niclosamide for Covid-19: bridging the gap
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Khalid J. Alzahrani, Athanasios Alexiou, Gaber El-Saber Batiha
Molecular Biology Reports. 2021; 48(12): 8195
[Pubmed]  [Google Scholar] [DOI]
3 Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Safaa Qusti,Eida M. Alshammari,Francis O. Atanu,Gaber El-Saber Batiha
Biomedicine & Pharmacotherapy. 2021; 143: 112193
[Pubmed]  [Google Scholar] [DOI]
4 Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Yaaser Q. Almulaiky,Natália Cruz-Martins,Gaber El-Saber Batiha
European Journal of Pharmacology. 2021; : 174196
[Pubmed]  [Google Scholar] [DOI]
5 Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Naeem Qusty,Natália Cruz-Martins,Gaber El-Saber Batiha
Pulmonary Pharmacology & Therapeutics. 2021; : 102008
[Pubmed]  [Google Scholar] [DOI]
6 Computational analysis of macrolides as SARS-CoV-2 main protease inhibitors: a pattern recognition study based on molecular topology and validated by molecular docking
Riccardo Zanni,Maria Galvez-Llompart,Jorge Galvez
New Journal of Chemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 Testosterone in COVID-19: An Adversary Bane or Comrade Boon
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Hani Faidah,Athanasios Alexiou,Gaber El-Saber Batiha
Frontiers in Cellular and Infection Microbiology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
8 Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Saleh M. Abdullah,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Cardiovascular Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
9 COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Susana G. Guerreiro,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Cardiovascular Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
10 COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,M. Alblihed,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
11 The Looming Effects of Estrogen in Covid-19: A Rocky Rollout
Hayder M. Al-kuraishy,Ali I. Al-Gareeb,Hani Faidah,Thabat J. Al-Maiahy,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Nutrition. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
12 Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
Amany Magdy Beshbishy,Victor B. Oti,Diaa E. Hussein,Ibrahim F. Rehan,Oluyomi S. Adeyemi,Nallely Rivero-Perez,Adrian Zaragoza-Bastida,Muhammad Ajmal Shah,Khaled Abouelezz,Helal F. Hetta,Natália Cruz-Martins,Gaber El-Saber Batiha
Frontiers in Public Health. 2021; 9
[Pubmed]  [Google Scholar] [DOI]
13 Multidrug treatment for COVID-19
Masashi Ohe,Ken Furuya,Houman Goudarzi
Drug Discoveries & Therapeutics. 2021;
[Pubmed]  [Google Scholar] [DOI]
14 COVID-19 and phosphodiesterase enzyme type 5 inhibitors
HayderM Al-Kuraishy,AliI Al-Gareeb,MarwaS Al-Niemi,AliK Al-Buhadily,NasserA Al-Harchan,Claire Lugnier
Journal of Microscopy and Ultrastructure. 2020; 8(4): 141
[Pubmed]  [Google Scholar] [DOI]
15 Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
Masashi Ohe,Ken Furuya,Houman Goudarzi
BioScience Trends. 2020;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article